Prokidney (PROK) Debt Ratio (2021 - 2022)
Prokidney's (PROK) quarterly Debt Ratio came in at 0.0 in Q2 2022, down 99.22% year-on-year from 0.04 in Q2 2021, and up 84.78% on a QoQ basis from 0.0 in Q1 2022.
Prokidney (PROK) Debt Ratio (2021 - 2022) Analysis & Trends
Prokidney (PROK) has 2 years of Debt Ratio data on file, last reported at 0.0 in Q2 2022.
- On a quarterly basis, Debt Ratio fell 99.22% year-over-year to 0.0 in Q2 2022; TTM through Jun 2022 was 0.0, a 99.22% decrease from a year earlier, with the FY2021 full-year figure at 0.0, changed N/A from the prior year.
- Debt Ratio for Q2 2022 stood at 0.0, up from 0.0 in the prior quarter.
- Over the last five years, Debt Ratio for PROK reached as high as 0.04 in Q2 2021 and fell as low as 0.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 1.41 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.11 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.04 |